Q1 + April 2020 Quarterly VC Update: Tip of the Iceberg?

With the onset of the COVID-19 crisis in March, we decided to include April data in our first 2020 report to better illustrate any early indicators of effects of the pandemic on the financing environment. Additionally, we have broken out specific statistics by month and industry (technology/life sciences/other) to offer […]

Employment Issues for U.S. Venture Capital Firms to Consider as They Prepare to Return to the Office

As the COVID-19 pandemic continues, most U.S. venture capital firms have been subject to federal, state or local directives to “shelter in place” since March. Thanks to the nature of the venture capital business, most firms were likely able to convert the bulk of their employees to a remote working […]

Initial Observations Regarding COVID-19’s Impact on Venture Capital Fund Raising

As much of the world shelters in place, nearly every client conversation we have with our venture capital fund clients comes around to some version of the questions “what are you seeing” and “will all of this impact our fund raising plans”.  We acknowledge the lack of clarity, at present, […]

SEC Relaxes Conditions of Form ADV Filing Extension

In response to the developing COVID-19 situation, on March 25, 2020 the SEC issued a new order to relax certain conditions contained in a previous order issued March 13, 2020 applicable to Exempt Reporting Advisers (“ERAs”) and Registered Investment Advisers (“RIAs”) who need more time to file annual amendments to […]

SEC Extension of FORM ADV Amendment Deadline

In response to the coronavirus disease COVID 19, the SEC has provided a conditional extension of the March 30, 2020 deadline for annual amendments to Form ADV. The extension applies to both Exempt Reporting Advisers (“ERAs”) and Registered Investment Advisers (“RIAs”).  RIAs’ brochure delivery and updating deadlines have also been […]